FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3104698003> ?p ?o ?g. }

• W3104698003 abstract "Abstract Dominantly inherited disorders are not typically considered therapeutic candidates for gene augmentation. Here, we utilized patient-specific induced pluripotent stem cell-derived retinal pigment epithelium (iPSC-RPE) to test the potential of gene augmentation to treat Best disease, a dominant macular dystrophy caused by over 200 missense mutations in BEST1 . Gene augmentation in iPSC-RPE fully restored BEST1 calcium-activated chloride channel activity and improved rhodopsin degradation in iPSC-RPE models of recessive bestrophinopathy and dominant Best disease caused by two different ion binding domain mutations. A dominant Best disease iPSC-RPE model that did not respond to gene augmentation showed normalization of BEST1 channel activity following CRISPR-Cas9 editing of the mutant allele. We then tested gene editing in all three dominant Best disease iPSC-RPE models, which produced premature stop codons exclusively within the mutant BEST1 alleles. Single-cell profiling demonstrated no adverse perturbation of RPE transcriptional programs in any model, although off-target analysis detected a silent genomic alteration in one model. These results suggest that gene augmentation is a viable first-line approach for some dominant Best disease patients and that non-responders are candidates for alternate approaches such as genome editing. However, testing genome editing strategies for on-target efficiency and off-target events using patient-matched iPSC-RPE model systems is warranted. In summary, personalized iPSC-RPE models can be used to select among a growing list of gene therapy options to maximize safety and efficacy while minimizing time and cost. Similar scenarios likely exist for other genotypically diverse channelopathies, expanding the therapeutic landscape for affected patients. Significance Dominantly inherited disorders pose distinct challenges for gene therapies, particularly in the face of extreme mutational diversity. We tested whether a broad gene replacement strategy could reverse the cellular phenotype of Best disease, a dominant blinding condition that targets retinal pigment epithelium (RPE). Using RPE generated from patient-specific induced pluripotent stem cells (iPSCs), we show that gene replacement functionally overcomes some, but not all, of the tested mutations. In comparison, all dominant Best disease models tested were phenotypically corrected after mutation-specific genome editing, although one off-target genomic alteration was discovered. Our results support a two-tiered approach to gene therapy for Best disease, guided by safety and efficacy testing in iPSC-RPE models to maximize personal and public health value." @default.
• W3104698003 created "2020-11-23" @default.
• W3104698003 creator A5000874602 @default.
• W3104698003 creator A5002751767 @default.
• W3104698003 creator A5005402909 @default.
• W3104698003 creator A5006104944 @default.
• W3104698003 creator A5023926295 @default.
• W3104698003 creator A5029839718 @default.
• W3104698003 creator A5031916745 @default.
• W3104698003 creator A5034234543 @default.
• W3104698003 creator A5038344150 @default.
• W3104698003 creator A5044539155 @default.
• W3104698003 creator A5045680577 @default.
• W3104698003 creator A5063210473 @default.
• W3104698003 creator A5063963894 @default.
• W3104698003 creator A5072591144 @default.
• W3104698003 creator A5078921485 @default.
• W3104698003 creator A5079942652 @default.
• W3104698003 creator A5082616445 @default.
• W3104698003 creator A5084459554 @default.
• W3104698003 creator A5087358894 @default.
• W3104698003 date "2019-10-08" @default.
• W3104698003 modified "2023-09-27" @default.
• W3104698003 title "Human iPSC modeling reveals mutation-specific responses to gene therapy in Best disease" @default.
• W3104698003 cites W1614724436 @default.
• W3104698003 cites W1957554463 @default.
• W3104698003 cites W1968076268 @default.
• W3104698003 cites W1996788258 @default.
• W3104698003 cites W2003171404 @default.
• W3104698003 cites W2009654164 @default.
• W3104698003 cites W2010066130 @default.
• W3104698003 cites W2020754695 @default.
• W3104698003 cites W2036176224 @default.
• W3104698003 cites W2048855120 @default.
• W3104698003 cites W2057962047 @default.
• W3104698003 cites W2095623631 @default.
• W3104698003 cites W2103693357 @default.
• W3104698003 cites W2104908096 @default.
• W3104698003 cites W2117381269 @default.
• W3104698003 cites W2149402050 @default.
• W3104698003 cites W2199356015 @default.
• W3104698003 cites W2252568502 @default.
• W3104698003 cites W2321178059 @default.
• W3104698003 cites W2414247940 @default.
• W3104698003 cites W2470801200 @default.
• W3104698003 cites W2557222554 @default.
• W3104698003 cites W2572978017 @default.
• W3104698003 cites W2582688531 @default.
• W3104698003 cites W2762226282 @default.
• W3104698003 cites W2766170687 @default.
• W3104698003 cites W2772961895 @default.
• W3104698003 cites W2781815848 @default.
• W3104698003 cites W2788789448 @default.
• W3104698003 cites W2792262786 @default.
• W3104698003 cites W2793264310 @default.
• W3104698003 cites W2799801940 @default.
• W3104698003 cites W2802665497 @default.
• W3104698003 cites W2810487964 @default.
• W3104698003 cites W2840212422 @default.
• W3104698003 cites W2888444358 @default.
• W3104698003 cites W2890721979 @default.
• W3104698003 cites W2899807648 @default.
• W3104698003 cites W2901998174 @default.
• W3104698003 cites W2908873329 @default.
• W3104698003 cites W2951012505 @default.
• W3104698003 cites W2981514644 @default.
• W3104698003 cites W2994709498 @default.
• W3104698003 doi "https://doi.org/10.1101/796581" @default.
• W3104698003 hasPublicationYear "2019" @default.
• W3104698003 type Work @default.
• W3104698003 sameAs 3104698003 @default.
• W3104698003 citedByCount "2" @default.
• W3104698003 countsByYear W31046980032019 @default.
• W3104698003 countsByYear W31046980032020 @default.
• W3104698003 crossrefType "posted-content" @default.
• W3104698003 hasAuthorship W3104698003A5000874602 @default.
• W3104698003 hasAuthorship W3104698003A5002751767 @default.
• W3104698003 hasAuthorship W3104698003A5005402909 @default.
• W3104698003 hasAuthorship W3104698003A5006104944 @default.
• W3104698003 hasAuthorship W3104698003A5023926295 @default.
• W3104698003 hasAuthorship W3104698003A5029839718 @default.
• W3104698003 hasAuthorship W3104698003A5031916745 @default.
• W3104698003 hasAuthorship W3104698003A5034234543 @default.
• W3104698003 hasAuthorship W3104698003A5038344150 @default.
• W3104698003 hasAuthorship W3104698003A5044539155 @default.
• W3104698003 hasAuthorship W3104698003A5045680577 @default.
• W3104698003 hasAuthorship W3104698003A5063210473 @default.
• W3104698003 hasAuthorship W3104698003A5063963894 @default.
• W3104698003 hasAuthorship W3104698003A5072591144 @default.
• W3104698003 hasAuthorship W3104698003A5078921485 @default.
• W3104698003 hasAuthorship W3104698003A5079942652 @default.
• W3104698003 hasAuthorship W3104698003A5082616445 @default.
• W3104698003 hasAuthorship W3104698003A5084459554 @default.
• W3104698003 hasAuthorship W3104698003A5087358894 @default.
• W3104698003 hasBestOaLocation W31046980031 @default.
• W3104698003 hasConcept C104317684 @default.
• W3104698003 hasConcept C107459253 @default.
• W3104698003 hasConcept C132455925 @default.
• W3104698003 hasConcept C144501496 @default.
• W3104698003 hasConcept C145103041 @default.

• next